Showing results (1531-1540 of 19,551) with videos related to

Sort By:
Pageof 1,956
BMC Cancer|April 18, 2015
Impact of kinesin Eg5 inhibition by 3,4-dihydropyrimidin-2(1H)-one derivatives on various breast cancer cell featuresBruna C Guido, Luciana M Ramos, Diego O Nolasco, et al.
BMC Cancer|August 28, 2025
Salvage involved-field versus extended-field chemoradiotherapy for postoperative lymph node metastasis in esophageal squamous cell carcinoma: a retrospective clinical studyWenqian Liu, Dongfang Ge, Tian Wang, et al.
BMC Cancer|August 29, 2025
Best practices for home nutritional management in postoperative gastric cancer patients: an evidence summaryWang Shanshan, Wen Lian, Dong Lu, et al.
BMC Cancer|August 6, 2016
Statin use and breast cancer survival: a nationwide cohort study in ScotlandÚna C Mc Menamin, Liam J Murray, Carmel M Hughes, et al.
BMC Cancer|August 7, 2016
Inconsistent results in the analysis of ALK rearrangements in non-small cell lung cancerJohanna S M Mattsson, Hans Brunnström, Verena Jabs, et al.
BMC Cancer|August 7, 2016
A nomogram for predicting pathological complete response in patients with human epidermal growth factor receptor 2 negative breast cancerXi Jin, Yi-Zhou Jiang, Sheng Chen, et al.
BMC Cancer|August 7, 2016
A retrospective analysis of Victorian and South Australian clinical registries for prostate cancer: trends in clinical presentation and management of the diseaseRasa Ruseckaite, Kerri Beckmann, Michael O'Callaghan, et al.
BMC Cancer|July 30, 2016
The effects of lymph node status on predicting outcome in ER+ /HER2- tamoxifen treated breast cancer patients using gene signaturesJessica G Cockburn, Robin M Hallett, Amy E Gillgrass, et al.
BMC Cancer|July 30, 2016
Pre-treatment MRI minimum apparent diffusion coefficient value is a potential prognostic imaging biomarker in cervical cancer patients treated with definitive chemoradiationDaniel Grossi Marconi, Jose Humberto Tavares Guerreiro Fregnani, Rodrigo Ribeiro Rossini, et al.
BMC Cancer|July 31, 2016
Heat shock protein 70-2 (HSP70-2) is a novel therapeutic target for colorectal cancer and is associated with tumor growthNirmala Jagadish, Deepak Parashar, Namita Gupta, et al.
Pageof 1,956